-5%
Levopa 110 is a combination medication containing levodopa and carbidopa, used to manage the symptoms of Parkinson’s disease, including tremors, muscle rigidity, and movement difficulties. It is considered one of the most effective treatments for controlling Parkinson’s symptoms.
- Swallow the tablet whole; do not crush, chew, or break it.
- It is best taken on an empty stomach.
- Avoid high-protein foods such as meat, poultry, eggs, milk, cottage cheese, Swiss cheese, and protein supplements around the time of dosing, as they may reduce the absorption of the medication.
- Taking the medicine at the same time every day helps maintain consistent drug levels in the body.
- If you miss a dose, take it as soon as you remember. Do not skip doses or stop treatment without consulting your doctor, even if your symptoms improve.
- The medication may cause dizziness, lightheadedness, or fainting, especially when standing up quickly. Rise slowly from sitting or lying positions.
- It can cause sudden sleepiness, so avoid driving or operating machinery until you know how the medicine affects you.
- Inform your doctor if you have liver disease, kidney disease, heart problems, dementia, psychosis, or other medical conditions.
- Regular monitoring of liver and kidney function may be recommended.
- Tell your doctor about all medicines you are taking, as several drugs can interact with Levopa 110.
- Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
- Immediate-release tablets: Usually started at 25 mg/100 mg every 8 hours or 10 mg/100 mg every 6–8 hours.
- The levodopa dose may be increased by 100 mg per day every 1–2 days as needed.
- Carbidopa intake should generally be 70–100 mg daily and should not exceed 200 mg per day.
- Levodopa intake should not exceed 800 mg daily.
- Controlled-release tablets: Typically started at 50 mg/200 mg every 12 hours and may be increased up to 1600 mg of levodopa per day, with doses spaced at least 6 hours apart.
Children
- Safety and effectiveness have not been established.
Renal or Hepatic Impairment
- Use cautiously, as safety and efficacy have not been fully established.
